“…Delanzomib [ 9 ] and ixazomib [ 10 ] were found to be active in the design of new drugs ( Figure 1 ). On the other hand, organoboron derivatives are important intermediates for various chemical transformations [ 11 , 12 , 13 , 14 , 15 ], such as Suzuki–Miyaura coupling [ 16 , 17 ], Petasis reaction [ 18 ], allylborations [ 19 ], oxidations [ 20 ] and so on. Thus, new methodologies for the synthesis of organoboron compounds were continuously developed by chemists in both laboratories and industry.…”